U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pseudomonas aeruginosa Infections

MedGen UID:
1375556
•Concept ID:
C0854135
•
Disease or Syndrome
Synonym: Pseudomonas aeruginosa Infection

Professional guidelines

PubMed

Management strategies for severe Pseudomonas aeruginosa infections.
Do Rego H, Timsit JF
Curr Opin Infect Dis 2023 Dec 1;36(6):585-595. Epub 2023 Oct 12 doi: 10.1097/QCO.0000000000000981. PMID: 37823536
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.
Reynolds D, Kollef M
Drugs 2021 Dec;81(18):2117-2131. Epub 2021 Nov 7 doi: 10.1007/s40265-021-01635-6. PMID: 34743315Free PMC Article
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.
Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S
Clin Microbiol Rev 2019 Sep 18;32(4) Epub 2019 Aug 28 doi: 10.1128/CMR.00031-19. PMID: 31462403Free PMC Article

Recent clinical studies

Etiology

Skin manifestations of Pseudomonas aeruginosa infections.
Spernovasilis N, Psichogiou M, Poulakou G
Curr Opin Infect Dis 2021 Apr 1;34(2):72-79. doi: 10.1097/QCO.0000000000000717. PMID: 33492004
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections.
Ibrahim D, Jabbour JF, Kanj SS
Curr Opin Infect Dis 2020 Dec;33(6):464-473. doi: 10.1097/QCO.0000000000000677. PMID: 33148986
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.
Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S
Clin Microbiol Rev 2019 Sep 18;32(4) Epub 2019 Aug 28 doi: 10.1128/CMR.00031-19. PMID: 31462403Free PMC Article
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L
Antimicrob Resist Infect Control 2018;7:79. Epub 2018 Jul 4 doi: 10.1186/s13756-018-0370-9. PMID: 29997889Free PMC Article
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.
Lodise TP Jr, Lomaestro B, Drusano GL
Clin Infect Dis 2007 Feb 1;44(3):357-63. Epub 2007 Jan 2 doi: 10.1086/510590. PMID: 17205441

Diagnosis

Mechanisms and Clinical Relevance of Pseudomonas aeruginosa Heteroresistance.
Chen Z
Surg Infect (Larchmt) 2023 Feb;24(1):27-38. Epub 2023 Jan 9 doi: 10.1089/sur.2022.349. PMID: 36622941
Skin manifestations of Pseudomonas aeruginosa infections.
Spernovasilis N, Psichogiou M, Poulakou G
Curr Opin Infect Dis 2021 Apr 1;34(2):72-79. doi: 10.1097/QCO.0000000000000717. PMID: 33492004
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L
Antimicrob Resist Infect Control 2018;7:79. Epub 2018 Jul 4 doi: 10.1186/s13756-018-0370-9. PMID: 29997889Free PMC Article
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
Stefani S, Campana S, Cariani L, Carnovale V, Colombo C, Lleo MM, Iula VD, Minicucci L, Morelli P, Pizzamiglio G, Taccetti G
Int J Med Microbiol 2017 Sep;307(6):353-362. Epub 2017 Jul 19 doi: 10.1016/j.ijmm.2017.07.004. PMID: 28754426
Cephalosporin antibiotics.
Thompson RL, Wright AJ
Mayo Clin Proc 1983 Feb;58(2):79-87. PMID: 6401833

Therapy

Management strategies for severe Pseudomonas aeruginosa infections.
Do Rego H, Timsit JF
Curr Opin Infect Dis 2023 Dec 1;36(6):585-595. Epub 2023 Oct 12 doi: 10.1097/QCO.0000000000000981. PMID: 37823536
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update.
Reynolds D, Kollef M
Drugs 2021 Dec;81(18):2117-2131. Epub 2021 Nov 7 doi: 10.1007/s40265-021-01635-6. PMID: 34743315Free PMC Article
Skin manifestations of Pseudomonas aeruginosa infections.
Spernovasilis N, Psichogiou M, Poulakou G
Curr Opin Infect Dis 2021 Apr 1;34(2):72-79. doi: 10.1097/QCO.0000000000000717. PMID: 33492004
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections.
Ibrahim D, Jabbour JF, Kanj SS
Curr Opin Infect Dis 2020 Dec;33(6):464-473. doi: 10.1097/QCO.0000000000000677. PMID: 33148986
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.
Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S
Clin Microbiol Rev 2019 Sep 18;32(4) Epub 2019 Aug 28 doi: 10.1128/CMR.00031-19. PMID: 31462403Free PMC Article

Prognosis

Direct prediction of carbapenem resistance in Pseudomonas aeruginosa by whole genome sequencing and metagenomic sequencing.
Liu B, Gao J, Liu XF, Rao G, Luo J, Han P, Hu W, Zhang Z, Zhao Q, Han L, Jiang Z, Zhou M
J Clin Microbiol 2023 Nov 21;61(11):e0061723. Epub 2023 Oct 12 doi: 10.1128/jcm.00617-23. PMID: 37823665Free PMC Article
Skin manifestations of Pseudomonas aeruginosa infections.
Spernovasilis N, Psichogiou M, Poulakou G
Curr Opin Infect Dis 2021 Apr 1;34(2):72-79. doi: 10.1097/QCO.0000000000000717. PMID: 33492004
Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.
Parkins MD, Somayaji R, Waters VJ
Clin Microbiol Rev 2018 Oct;31(4) Epub 2018 Aug 29 doi: 10.1128/CMR.00019-18. PMID: 30158299Free PMC Article
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L
Antimicrob Resist Infect Control 2018;7:79. Epub 2018 Jul 4 doi: 10.1186/s13756-018-0370-9. PMID: 29997889Free PMC Article
Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis.
Stefani S, Campana S, Cariani L, Carnovale V, Colombo C, Lleo MM, Iula VD, Minicucci L, Morelli P, Pizzamiglio G, Taccetti G
Int J Med Microbiol 2017 Sep;307(6):353-362. Epub 2017 Jul 19 doi: 10.1016/j.ijmm.2017.07.004. PMID: 28754426

Clinical prediction guides

Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models.
Holger DJ, El Ghali A, Bhutani N, Lev KL, Stamper K, Kebriaei R, Kunz Coyne AJ, Morrisette T, Shah R, Alexander J, Lehman SM, Rojas LJ, Marshall SH, Bonomo RA, Rybak MJ
Antimicrob Agents Chemother 2023 Nov 15;67(11):e0057823. Epub 2023 Oct 19 doi: 10.1128/aac.00578-23. PMID: 37855639Free PMC Article
Direct prediction of carbapenem resistance in Pseudomonas aeruginosa by whole genome sequencing and metagenomic sequencing.
Liu B, Gao J, Liu XF, Rao G, Luo J, Han P, Hu W, Zhang Z, Zhao Q, Han L, Jiang Z, Zhou M
J Clin Microbiol 2023 Nov 21;61(11):e0061723. Epub 2023 Oct 12 doi: 10.1128/jcm.00617-23. PMID: 37823665Free PMC Article
Genomic and Metabolic Characteristics of the Pathogenicity in Pseudomonas aeruginosa.
de Sousa T, Hébraud M, Dapkevicius MLNE, Maltez L, Pereira JE, Capita R, Alonso-Calleja C, Igrejas G, Poeta P
Int J Mol Sci 2021 Nov 29;22(23) doi: 10.3390/ijms222312892. PMID: 34884697Free PMC Article
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L
Antimicrob Resist Infect Control 2018;7:79. Epub 2018 Jul 4 doi: 10.1186/s13756-018-0370-9. PMID: 29997889Free PMC Article
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy.
Lodise TP Jr, Lomaestro B, Drusano GL
Clin Infect Dis 2007 Feb 1;44(3):357-63. Epub 2007 Jan 2 doi: 10.1086/510590. PMID: 17205441

Recent systematic reviews

A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis.
Singh J, Yeoh E, Fitzgerald DA, Selvadurai H
Paediatr Respir Rev 2023 Dec;48:3-9. Epub 2023 Aug 11 doi: 10.1016/j.prrv.2023.08.001. PMID: 37598024
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications.
Maraolo AE, Mazzitelli M, Trecarichi EM, Buonomo AR, Torti C, Gentile I
Int J Antimicrob Agents 2020 Mar;55(3):105891. Epub 2020 Jan 8 doi: 10.1016/j.ijantimicag.2020.105891. PMID: 31923569
Risk factors for hospitalized patients with resistant or multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.
Raman G, Avendano EE, Chan J, Merchant S, Puzniak L
Antimicrob Resist Infect Control 2018;7:79. Epub 2018 Jul 4 doi: 10.1186/s13756-018-0370-9. PMID: 29997889Free PMC Article
Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M, Lador A, Grozinsky-Glasberg S, Leibovici L
Cochrane Database Syst Rev 2014 Jan 7;2014(1):CD003344. doi: 10.1002/14651858.CD003344.pub3. PMID: 24395715Free PMC Article
Association between healthcare water systems and Pseudomonas aeruginosa infections: a rapid systematic review.
Loveday HP, Wilson JA, Kerr K, Pitchers R, Walker JT, Browne J
J Hosp Infect 2014 Jan;86(1):7-15. Epub 2013 Oct 14 doi: 10.1016/j.jhin.2013.09.010. PMID: 24289866

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...